Nov 12, 2019
Diplomat Announces 3rd Quarter Financial Results; Updates 2019 Guidance
Oct 30, 2019
Diplomat to Release Third-Quarter 2019 Operating Results Nov. 12
Oct 16, 2019
Diplomat Announces Sale of Certain Assets of Envoy Health Management, LLC to Diligent Health Solutions, LLC
Oct 02, 2019
Diplomat Announces Promotion of David Skomo to Chief Operating Officer of CastiaRx
Aug 09, 2019
Diplomat Announces 2nd Quarter Financial Results; Updates 2019 Guidance
Aug 09, 2019
Diplomat Announces Review of Strategic Alternatives
Aug 08, 2019
Diplomat signs exclusive practice-based infusion agreement with Allergy Partners
Jul 18, 2019
Diplomat to Release Second-Quarter 2019 Operating Results August 9
Jul 09, 2019
Diplomat Launches Empower Ecosystem Patient Support Digital Library
May 07, 2019
Diplomat Announces 1st Quarter Financial Results
May 06, 2019
Diplomat Appoints Dave Loschinskey as Chief Operating Officer
Apr 25, 2019
Diplomat Using SMRxT Technology to Enhance Patient Care
Apr 17, 2019
Diplomat to Release First-Quarter 2019 Operating Results May 7, Participate in Bank of America Merrill Lynch Healthcare Conference May 14
Apr 15, 2019
DPLO CLASS ACTION REMINDER: Hagens Berman Reminds Diplomat Pharmacy (DPLO) of Securities Class Action, Encourages Investors to Contact the Firm
Apr 10, 2019
Diplomat Expands AdhereTech Relationship as Program Shows Increased Adherence and Persistence
Apr 09, 2019
Diplomat Grants Chief Financial Officer Dan Davison Inducement Awards Pursuant to NYSE Rule 303A.08
Mar 15, 2019
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Diplomat Pharmacy, Inc. To Contact The Firm
Mar 15, 2019
Diplomat Appoints Daniel Davison as Chief Financial Officer
Mar 13, 2019
Diplomat Announces Details of Rescheduled 2018 Results Conference Call
Mar 04, 2019
EnvoyHealth to Offer Mango Health Mobile App